Scripps Laboratories specializes in the development and production of a wide range of recombinant proteins, hormones, and antibodies tailored for clinical diagnostics and research applications. Their offerings include recombinant pituitary hormones, cardiac markers, and metabolic markers, which are designed to meet the rigorous performance standards required in diagnostic assays. The company emphasizes the importance of creating reliable and reproducible products, ensuring that each recombinant protein undergoes thorough testing for purity, stability, and efficacy before being released. This meticulous approach has led to their recombinants being validated for use in assay panels by major clinical diagnostic corporations, effectively replacing native proteins that have historically been used.

In addition to their focus on recombinant proteins, Scripps Laboratories provides a variety of reagents and buffers to support the stability and effectiveness of their products. Their catalog includes antibodies—both monoclonal and polyclonal—specific to various hormones and proteins, as well as dilution buffers and stabilizers for assay optimization. The company is committed to sustainability, sourcing recombinant proteins from cell lines that can be grown on-demand, thus ensuring a consistent supply of high-quality materials. This innovative approach not only addresses the challenges associated with the procurement of native tissues but also positions Scripps Laboratories as a leader in the evolving landscape of clinical diagnostics.

United States

Scripps Laboratories is a biotechnology company that specializes in bulk manufacturing high quality proteins and immunoreagents for the diagnostic industry and research community.

Scripps Laboratories

Company Details